<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Homepage WeiZhu </title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="bootstrap-superhero.css">
    <link rel="stylesheet" href="style.css">
    <script src="https://code.jquery.com/jquery-3.3.1.slim.min.js" integrity="sha384-q8i/X+965DzO0rT7abK41JStQIAqVgRVzpbzo5smXKp4YfRvH+8abtTE1Pi6jizo" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.7/umd/popper.min.js" integrity="sha384-UO2eT0CpHqdSJQ6hJty5KVphtPhzWj9WO1clHTMGa3JDZwrnQq4sF86dIHNDz0W1" crossorigin="anonymous"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/js/bootstrap.min.js" integrity="sha384-JjSmVgyd0p3pXB1rRibZUAYoIIy6OrQ6VrjIEaFf/nJGzIxFDsf4x0xIM+B07jRM" crossorigin="anonymous"></script>
</head>
<body>
  <nav class="navbar navbar-inverse">
    <div class="container-fluid">
      <div class="navbar-header">
        <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-2">
          <span class="sr-only">Toggle navigation</span>
          <span class="icon-bar"></span>
          <span class="icon-bar"></span>
          <span class="icon-bar"></span>
        </button>
        <a class="navbar-brand" href="bonus-index.html">Home</a>
      </div>
  
      <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-2">
        <ul class="nav navbar-nav">
          <li class="active"><a href="https://www.linkedin.com/in/wei-chester-zhu-84b336109/" target="_blank">LinkedIn<span class="sr-only">(current)</span></a></li>
          <li><a href="https://scholar.google.com/citations?view_op=list_works&hl=en&user=qj8pqxEAAAAJ&gmla=AJsN-F69QaBARR4vy3Duy9U_MeS0wj7i1UsNiJWxCVf_zm7TuRVTzUeiPLaALc6SFt7LSnJpJo9J0vV8Nfjv-_4IJO479-0srI15F4MRxqfKLuvcBV3_iQZk3voBcS5XDuipMGrB7E-R" target="_blank">Google Scholar</a></li>
          <li><a href="https://github.com/wzhu0815" target="_blank">GitHub</a></li>
          <li class="dropdown">
            <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">Research <span class="caret"></span></a>
            <ul class="dropdown-menu" role="menu">
              <li><a href="mbi.html">Mechanism-based Inactivators</a></li>
              <li class="divider"></li>
              <li><a href="ki.html">Kinase Inhibitors</a></li>
              <li class="divider"></li>
              <li><a href="ch.html">C-H Activation Methodology</a></li>
              
            </ul>
          </li>
        </ul>
        <ul class="nav navbar-nav navbar-right">
          <li><a href="mailto:wei.zhu@northwestern.com">Email Me</a></li>
        </ul>
      </div>
    </div>
  </nav>

    <div class="container">
        <div class="row">
          <div class="col-md-7">
              <h2 class="cadetblue">Introduction </h2>
              <hr>
            <img src="photo_wei.jpg" alt="Wei Photo" id= 'smallfig'  style="float:left">
            <h3>Wei Zhu (Ph.D.) </h3>
            <br>
            <h4>Postdoctoral Fellow at Northwestern University, Present</h4>
            <h4>Ph.D. Shanghai Institute of Materia Medica, 2016</h4>
            <h4>B.S.,East China University of Science andTechnology, 2011</h4>  
            <div class="row">
              <div class="col-md">
                <p>My long-term research mainly focuses on the design, synthesis, and evaluation of small molecules against the corresponding potential targets for the treatment of cancers. My academic training and research experience have provided me with an excellent background in multiple chemical disciplines including drug discovery, organic synthesis, phytochemistry, analytical chemistry, and pharmaceutics. </p>
                <p>During my undergraduate and graduate period, my research experience was initiated at Prof. Hong Liu’s lab for the development of new organic methodologies for the facile construction of privilege scaffolds, in which it helped me to be familiar with reaction mechanism, spectroscopy and chromatography. During my Ph.D. candidate period, I was mainly working on the synthesis and structure-activity relationship (SAR) study of kinase inhibitors. After the comprehensive in vitro evaluation, one multitargeted protein kinase inhibitor and one c-Met inhibitor were found to show significant in vivo anti-cancer activities with desired PK properties, respectively. All the academic training during the college education helped me to establish a solid foundation of my chemical expertise and experimental capability as well as my long-term interests in medicinal chemistry area The research experience in the industry provided me an opportunity to learn the standard procedures for the process chemistry development of active pharmaceutical ingredients (APIs). During that period, my understandings and insights on reaction mechanism, synthetic route design, analytical chemistry were greatly enhanced.</p>
                <p>Currently, I work in Prof. Richard B. Silverman’s group at Northwestern University to discover new inactivators of ornithine aminotransferases, which was gradually recognized as a potential target for hepatocellular carcinoma (HCC). Besides, the overexpression of OAT was also found in other related cancers, such as non-small cell lung cancer (NSCLC), breast cancer, colorectal cancer and glioblastoma multiforme (GBM). Very recently, we discovered a series of new inactivators with great improved potency and suitable pharmacokinetic properties. Therefore, I am willing to apply for the basic science initiative award from Robert H. Lurie comprehensive cancer center to study anti-cancer effects of new OAT inactivators.</p>
              </div>
            </div>
          </div>

          <div class="col-md-1"></div>
          <div class="col-md-4">
            <h2 class="cadetblue">Research</h2>
            <hr>
            <div class="row">
              <h5><a href="mbi.html">Mechanism-based Inactivators</a></h5>
                <div class="col-md"><a href="https://pubs.acs.org/doi/abs/10.1021/jacs.0c00193" target="_blank"><img src="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jacsat/2020/jacsat.2020.142.issue-10/jacs.0c00193/20200304/images/medium/ja0c00193_0012.gif" alt="Mechanism-based Inactivators" ></a></div>
                <hr>
                </div>
                <div class="row">
                  <h5><a href="ki.html">Kinase Inhibitors</a></h5>
                <div class="col-md"><a href="https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b00076"  target="_blank"><img src="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00076/20170721/images/medium/jm-2017-00076u_0015.gif" alt="Kinase Inhibitors"></a></div>
                <hr>
            </div>

            <div class="row">
              <h5><a href="ch.html">C-H Activation Methodology</a></h5>
                <div class="col-md"><a href="https://pubs.rsc.org/--/content/articlelanding/2014/cc/c4cc03837a/unauth#!divAbstract" target="_blank"><img src="https://pubs.rsc.org/--/Image/Get?imageInfo.ImageType=GA&imageInfo.ImageIdentifier.ManuscriptID=C4CC03837A&imageInfo.ImageIdentifier.Year=2014" alt="C-H Activation Methodology" ></a></div>
                <hr>
              </div>

          </div>

          </div>
  
    </div>
    
</body>

</html>